bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2500
-0.0119 (-4.54%)
Mar 31, 2025, 1:35 PM EDT - Market open
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $3.90 million as of March 31, 2025. Its market cap has decreased by -82.23% in one year.
Market Cap
3.90M
Enterprise Value
5.01M
1-Year Change
-82.23%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $3.90M, a decrease of -91.35%. That is a compound annual growth rate of -61.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 4.08M | -71.22% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 722.75B |
| UnitedHealth Group | 478.77B |
| Johnson & Johnson | 400.42B |
| AbbVie | 370.23B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 228.93B |
| Merck & Co. | 224.54B |